Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Tuberculosis and immune thrombocytopenia

Manisha Madkaikar¹, Kanjaksha Ghosh, Farah Jijina

¹Institute of Immunohaematology, 13th Floor, New Multistoreyed Bldg, KEM Hospital Campus, Parel, Mumbai-400 012, India.

|August 6, 2002

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Low Dose Escalating Factor Concentrate Prophylaxis in Patients with Severe Hemophilia in a Comprehensive Hemophilia Care Centre of Western India.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026

Same author

Common Variable Immunodeficiency Disorder: A Decade of Insights from a Cohort of 150 Patients in India and the Use of Machine Learning Algorithms to Predict Severity.

Journal of clinical immunology·2025

Same author

Low-dose emicizumab prophylaxis in patients with severe hemophilia A: a retrospective study bringing new hope for our patients.

Journal of thrombosis and haemostasis : JTH·2023

Same author

Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study.

Journal of cancer research and therapeutics·2023

Same author

Editorial: Sickle cell disease in the 21st century-Morbidity to molecular biology.

Frontiers in medicine·2022

Same author

Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes.

Scientific reports·2022